Yasuhiro Yuasa

Tokushima, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Plasma Biomarkers Associated with Clinical Outcomes of FOLFIRI Plus Ramucirumab in RAS Wild-Type Metastatic Colorectal Cancer: The JACCRO CC-16AR Trial.

Plasma Biomarkers Associated with Clinical Outcomes of FOLFIRI Plus Ramucirumab in RAS Wild-Type Metastatic Colorectal Cancer: The JACCRO CC-16AR Trial.

Journal: Targeted oncology
Published: November 20, 2025

Study on prediction of early adverse events by CapeOX therapy in patients with colorectal cancer.

Study on prediction of early adverse events by CapeOX therapy in patients with colorectal cancer.

Journal: The journal of medical investigation : JMI
Published: May 12, 2024

Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer.

Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer.

Journal: Nature medicine
Published: September 29, 2023

Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial.

Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial.

Journal: JAMA
Published: April 18, 2023

A case of aortoduodenal fistula presenting with postoperative lymphatic leakage.

A case of aortoduodenal fistula presenting with postoperative lymphatic leakage.

Journal: International journal of surgery case reports
Published: April 05, 2022

Phase II study of trifluridine/tipiracil plus bevacizumab by RAS mutation status in patients with metastatic colorectal cancer refractory to standard therapies: JFMC51-1702-C7.

Phase II study of trifluridine/tipiracil plus bevacizumab by RAS mutation status in patients with metastatic colorectal cancer refractory to standard therapies: JFMC51-1702-C7.

Journal: ESMO open
Published: September 17, 2020

Pancreaticoduodenectomy after distal gastrectomy: A case series.

Pancreaticoduodenectomy after distal gastrectomy: A case series.

Journal: International journal of surgery case reports
Published: August 30, 2020

A phase II study of FOLFOXIRI plus bevacizumab as initial chemotherapy for patients with untreated metastatic colorectal cancer: TRICC1414 (BeTRI).

A phase II study of FOLFOXIRI plus bevacizumab as initial chemotherapy for patients with untreated metastatic colorectal cancer: TRICC1414 (BeTRI).

Journal: International journal of clinical oncology
Published: August 16, 2020

Impact of preoperative chemotherapy as initial treatment for advanced gastric cancer with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) or localized peritoneal metastasis (P1a): a multi-institutional retrospective study.

Impact of preoperative chemotherapy as initial treatment for advanced gastric cancer with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) or localized peritoneal metastasis (P1a): a multi-institutional retrospective study.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: June 19, 2020

Secondary aorto-duodenal fistula successfully treated with a novel surgical method: A case report.

Secondary aorto-duodenal fistula successfully treated with a novel surgical method: A case report.

Journal: International journal of surgery case reports
Published: March 18, 2020

Repair of a perforated duodenal diverticulum using intraduodenal suture in 94 year old woman: A case report.

Repair of a perforated duodenal diverticulum using intraduodenal suture in 94 year old woman: A case report.

Journal: International journal of surgery case reports
Published: February 23, 2020

Unresectable Advanced Gastric Cancer with Skin Invasion followed by Total Gastrectomy after Second-Line Chemotherapy.

Unresectable Advanced Gastric Cancer with Skin Invasion followed by Total Gastrectomy after Second-Line Chemotherapy.

Journal: Case reports in oncology
Published: July 24, 2019
Showing 1-12 of 26

Last Updated: 09/26/2026